Table 1 Definitions of prior MS treatment groups (core and extension analysis)
From: Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis
Group | Definition | Maximum time point available |
|---|---|---|
Treatment naive | Patients with no prior DMT or DMT > 2 years prior to randomization | Year 13 |
Previously treated with another DMT | Patients whose most recent prior DMT was discontinued > 6 months to 2 years prior to randomization | Year 13 |
Recently treated with another DMT | Patients whose most recent prior DMT was discontinued within 6 months prior to randomization (excluded patients who recently received teriflunomide 7 mg) | Year 12 |